Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

NCT05891964 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Secukinumab Injection

Sponsor

Jinnah Postgraduate Medical Centre